Cholangiocarcinoma—controversies and challenges (original) (raw)

• Welzel, T. M. et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin. Gastroenterol. Hepatol. 5, 1221–1228 (2007).
  PubMed PubMed Central Google Scholar
• Shaib, Y. H. et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am. J. Gastroenterol. 102, 1016–1021 (2007).
  PubMed Google Scholar
• Welzel, T. M., McGlynn, K. A., Hsing, A. W., O'Brien, T. R. & Pfeiffer, R. M. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J. Natl Cancer Inst. 98, 873–875 (2006).
  PubMed Google Scholar
• Patel, T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2, 10 (2002).
  PubMed PubMed Central Google Scholar
• Patel, T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33, 1353–1357 (2001).
  CAS PubMed Google Scholar
• Patel, T. Cholangiocarcinoma. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 33–42 (2006).
  PubMed Google Scholar
• DeOliveira, M. L. et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann. Surg. 245, 755–762 (2007).
  PubMed PubMed Central Google Scholar
• Nagino, M. et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann. Surg. 243, 364–372 (2006).
  PubMed PubMed Central Google Scholar
• Hemming, A. W., Reed, A. I., Fujita, S., Foley, D. P. & Howard, R. J. Surgical management of hilar cholangiocarcinoma. Ann. Surg. 241, 693–699 (2005).
  PubMed PubMed Central Google Scholar
• Rea, D. J., Rosen, C. B., Nagorney, D. M., Heimbach, J. K. & Gores, G. J. Transplantation for cholangiocarcinoma: when and for whom? Surg. Oncol. Clin. N. Am. 18, 325–337 (2009).
  PubMed Google Scholar
• Valle, J. et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N. Engl. J. Med. 362, 1273–1281 (2010).
  CAS PubMed Google Scholar
• Gao, F., Bai, Y., Ma, S. R., Liu, F. & Li, Z. S. Systematic review: photodynamic therapy for unresectable cholangiocarcinoma. J. Hepatobiliary Pancreat. Sci. 17, 125–131 (2010).
  PubMed Google Scholar
• Ortner, M. A. Photodynamic therapy for cholangiocarcinoma: overview and new developments. Curr. Opin. Gastroenterol. 25, 472–476 (2009).
  CAS PubMed Google Scholar
• Quyn, A. J., Ziyaie, D., Polignano, F. M. & Tait, I. S. Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford) 11, 570–577 (2009).
  Google Scholar
• Ortner, M. E. et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125, 1355–1363 (2003).
  PubMed Google Scholar
• Jinawath, N. et al. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma. Hepatology 44, 1025–1038 (2006).
  CAS PubMed Google Scholar
• Yang, B., House, M. G., Guo, M., Herman, J. G. & Clark, D. P. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma. Mod. Pathol. 18, 412–420 (2005).
  CAS PubMed Google Scholar
• Xu, M. J. et al. Identification and characterization of microRNAs in Clonorchis sinensis of human health significance. BMC Genomics 11, 521 (2010).
  PubMed PubMed Central Google Scholar
• Kawahigashi, Y. et al. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. J. Nippon Med. Sch. 76, 188–197 (2009).
  CAS PubMed Google Scholar
• Meng, F. et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130, 2113–2129 (2006).
  CAS PubMed Google Scholar
• Nakeeb, A. et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann. Surg. 224, 463–473 (1996).
  CAS PubMed PubMed Central Google Scholar
• Sano, T. et al. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann. Surg. Oncol. 15, 590–599 (2008).
  PubMed Google Scholar
• Ebata, T. et al. The concept of perihilar cholangiocarcinoma is valid. Br. J. Surg. 96, 926–934 (2009).
  CAS PubMed Google Scholar
• Klatskin, G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am. J. Med. 38, 241–256 (1965).
  CAS PubMed Google Scholar
• Farges, O. & Fuks, D. Clinical presentation and management of intrahepatic cholangiocarcinoma. Gastroenterol. Clin. Biol. 34, 191–199 (2010).
  CAS PubMed Google Scholar
• Gatto, M. & Alvaro, D. Cholangiocarcinoma: risk factors and clinical presentation. Eur. Rev. Med. Pharmacol. Sci. 14, 363–367 (2010).
  CAS PubMed Google Scholar
• Khan, S. A., Toledano, M. B. & Taylor-Robinson, S. D. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10, 77–82 (2008).
  CAS Google Scholar
• Singh, P. & Patel, T. Advances in the diagnosis, evaluation and management of cholangiocarcinoma. Curr. Opin. Gastroenterol. 22, 294–299 (2006).
  PubMed Google Scholar
• Shaib, Y. H., El-Serag, H. B., Davila, J. A., Morgan, R. & McGlynn, K. A. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128, 620–626 (2005).
  PubMed Google Scholar
• Chung, Y. E. et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29, 683–700 (2009).
  PubMed Google Scholar
• Yamasaki, S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J. Hepatobiliary Pancreat. Surg. 10, 288–291 (2003).
  PubMed Google Scholar
• Slattery, J. M. & Sahani, D. V. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist 11, 913–922 (2006).
  PubMed Google Scholar
• Chung, Y. E. et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29, 683–700 (2009).
  PubMed Google Scholar
• Nathan, H. & Pawlik, T. M. Staging of intrahepatic cholangiocarcinoma. Curr. Opin. Gastroenterol. 26, 269–273 (2010).
  CAS PubMed Google Scholar
• Edge, S. et al. (Eds) AJCC Cancer Staging Manual 7th edn (Springer, Chicago, 2009).
  Google Scholar
• Farges, O. et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer doi:10.1002/cncr.25712.
  PubMed Google Scholar
• Kokudo, N. & Arita, J. Staging for intrahepatic cholangiocarcinoma. Liver Int. 30, 931–933 (2010).
  PubMed Google Scholar
• Nathan, H. et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann. Surg. Oncol. 16, 14–22 (2009).
  PubMed Google Scholar
• Carpizo, D. R. & D'Angelica, M. Management and extent of resection for intrahepatic cholangiocarcinoma. Surg. Oncol. Clin. N. Am. 18, 289–305 (2009).
  PubMed Google Scholar
• Giuliante, F. et al. Liver resection for intrahepatic cholangiocarcinoma. Tumori 91, 487–492 (2005).
  PubMed Google Scholar
• Poultsides, G. A., Zhu, A. X., Choti, M. A. & Pawlik, T. M. Intrahepatic cholangiocarcinoma. Surg. Clin. North Am. 90, 817–837 (2010).
  PubMed Google Scholar
• Yokoyama, Y. et al. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br. J. Surg. 97, 1260–1268 (2010).
  CAS PubMed Google Scholar
• Murakami, Y. et al. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann. Surg. Oncol. doi: 10.1245/s10434-010-1325-4.
  PubMed Google Scholar
• Burger, I. et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J. Vasc. Interv. Radiol. 16, 353–361 (2005).
  PubMed Google Scholar
• Ahmadzadehfar, H., Biersack, H. J. & Ezziddin, S. Radioembolization of liver tumors with yttrium-90 microspheres. Semin. Nucl. Med. 40, 105–121 (2010).
  PubMed Google Scholar
• Hong, K. & Geschwind, J. F. Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma. Semin. Oncol. 37, 110–117 (2010).
  PubMed Google Scholar
• Kiefer, M. V. et al. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. Cancer doi:10.1002/cncr.25625.
  PubMed Google Scholar
• Carrafiello, G. et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience. Cardiovasc. Intervent. Radiol. 33, 835–839 (2010).
  PubMed Google Scholar
• Chiou, Y. Y. et al. Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma. Kaohsiung J. Med. Sci. 21, 304–309 (2005).
  PubMed Google Scholar
• Kim, J. H. et al. Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection. Eur. J. Radiol. doi:10.1016/j.ejrad.2010.09.019.
  PubMed Google Scholar
• Kopek, N., Holt, M. I., Hansen, A. T. & Hoyer, M. Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother. Oncol. 94, 47–52 (2010).
  PubMed Google Scholar
• Czito, B. G., Anscher, M. S. & Willett, C. G. Radiation therapy in the treatment of cholangiocarcinoma. Oncology (Williston Park) 20, 873–884 (2006).
  Google Scholar
• Chen, Y. X. et al. Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients. BMC Cancer 10, 492 (2010).
  PubMed PubMed Central Google Scholar
• Tse, R. V. et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J. Clin. Oncol. 26, 657–664 (2008).
  PubMed Google Scholar
• Glimelius, B. et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann. Oncol. 7, 593–600 (1996).
  CAS PubMed Google Scholar
• Hezel, A. F. & Zhu, A. X. Systemic therapy for biliary tract cancers. Oncologist 13, 415–423 (2008).
  CAS PubMed Google Scholar
• Mazhar, D., Stebbing, J. & Bower, M. Chemotherapy for advanced cholangiocarcinoma: what is standard treatment? Future Oncol. 2, 509–514 (2006).
  CAS PubMed Google Scholar
• Park, J. et al. Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study. Gut Liver 3, 298–305 (2009).
  CAS PubMed PubMed Central Google Scholar
• Cho, S. Y. et al. Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann. Surg. Oncol. 17, 1823–1830 (2010).
  PubMed Google Scholar
• Kassahun, W. T. & Jonas, S. Spectrum of benign lesions mimicking a malignant stricture at the liver hilum. Rev. Recent Clin. Trials 4, 185–194 (2009).
  PubMed Google Scholar
• Sasaki, R. et al. Evaluation of UICC-TNM and JSBS staging systems for surgical patients with extrahepatic cholangiocarcinoma. Langenbecks Arch. Surg. 395, 615–623 (2010).
  PubMed Google Scholar
• Bismuth, H. & Corlette, M. B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg. Gynecol. Obstet. 140, 170–178 (1975).
  CAS PubMed Google Scholar
• Bismuth, H., Nakache, R. & Diamond, T. Management strategies in resection for hilar cholangiocarcinoma. Ann. Surg. 215, 31–38 (1992).
  CAS PubMed PubMed Central Google Scholar
• Jarnagin, W. R. et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 234, 507–517 (2001).
  CAS PubMed PubMed Central Google Scholar
• Blechacz, B. R., Sanchez, W. & Gores, G. J. A conceptual proposal for staging ductal cholangiocarcinoma. Curr. Opin. Gastroenterol. 25, 238–239 (2009).
  PubMed PubMed Central Google Scholar
• Connor, S. et al. The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J. Gastrointest. Surg. 9, 476–480 (2005).
  PubMed Google Scholar
• El-Hanafy, E. Pre-operative biliary drainage in hilar cholangiocarcinoma, benefits and risks, single center experience. Hepatogastroenterology 57, 414–419 (2010).
  PubMed Google Scholar
• Liu, F., Li, Y., Wei, Y. & Li, B. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig. Dis. Sci. doi:10.1007/s10620-010-1338-7.
  PubMed Google Scholar
• Nagino, M. et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J. Hepatobiliary Pancreat. Surg. 15, 25–30 (2008).
  PubMed PubMed Central Google Scholar
• Regimbeau, J. M. et al. Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC Study Group. J. Gastrointest. Surg. doi:10.1007/s11605-011-1414-0.
  PubMed Google Scholar
• Shimizu, H. et al. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann. Surg. 251, 281–286 (2010).
  PubMed Google Scholar
• Lee, S. G. et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J. Hepatobiliary Pancreat Sci. 17, 476–589 (2010).
  PubMed Google Scholar
• Neuhaus, P. et al. Extended resections for hilar cholangiocarcinoma. Ann. Surg. 230, 808–818 (1999).
  CAS PubMed PubMed Central Google Scholar
• Jarnagin, W. R. et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 234, 507–517 (2001).
  CAS PubMed PubMed Central Google Scholar
• Capussotti, L., Muratore, A., Polastri, R., Ferrero, A. & Massucco, P. Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival. J. Am. Coll. Surg. 195, 641–647 (2002).
  PubMed Google Scholar
• Seyama, Y. et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann. Surg. 238, 73–83 (2003).
  PubMed PubMed Central Google Scholar
• Kawasaki, S. et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann. Surg. 238, 84–92 (2003).
  PubMed PubMed Central Google Scholar
• Hemming, A. W., Reed, A. I., Fujita, S., Foley, D. P. & Howard, R. J. Surgical management of hilar cholangiocarcinoma. Ann. Surg. 241, 693–699 (2005).
  PubMed PubMed Central Google Scholar
• Sano, T. et al. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann. Surg. 244, 240–247 (2006).
  PubMed PubMed Central Google Scholar
• Shimizu, H. et al. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann. Surg. 251, 281–286 (2010).
  PubMed Google Scholar
• Nagino, M. et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann. Surg. 252, 115–123 (2010).
  PubMed Google Scholar
• Anderson, C. & Kim, R. Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions. Cancer Treat. Rev. 35, 322–327 (2009).
  PubMed Google Scholar
• Sagawa, N., Kondo, S., Morikawa, T., Okushiba, S. & Katoh, H. Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma. Surg. Today 35, 548–552 (2005).
  PubMed Google Scholar
• Vern-Gross, T. Z. et al. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. Int. J. Radiat. Oncol. Biol. Phys. doi:10.1016/j.ijrobp.2010.05.001.
  Google Scholar
• Schoenthaler, R. et al. Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann. Surg. 219, 267–274 (1994).
  CAS PubMed PubMed Central Google Scholar
• Rea, D. J. et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann. Surg. 242, 451–458 (2005).
  PubMed PubMed Central Google Scholar
• Soderlund, C. & Linder, S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest. Endosc. 63, 986–995 (2006).
  PubMed Google Scholar
• Brugge, W. R. Endoscopic techniques to diagnose and manage biliary tumors. J. Clin. Oncol. 23, 4561–4565 (2005).
  PubMed Google Scholar
• Simmons, D. T. et al. A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma. Am. J. Gastroenterol. 101, 1792–1796 (2006).
  PubMed Google Scholar
• Qian, X. J., Zhai, R. Y., Dai, D. K., Yu, P. & Gao, L. Treatment of malignant biliary obstruction by combined percutaneous transhepatic biliary drainage with local tumor treatment. World J. Gastroenterol. 12, 331–335 (2006).
  PubMed PubMed Central Google Scholar
• Nag, S., DeHaan, M., Scruggs, G., Mayr, N. & Martin, E. W. Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 64, 736–744 (2006).
  PubMed Google Scholar
• Shim, C. S. et al. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy 37, 425–433 (2005).
  CAS PubMed Google Scholar
• Matull, W. R. et al. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int. 31, 99–107 (2011).
  CAS PubMed Google Scholar
• Witzigmann, H. et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann. Surg. 244, 230–239 (2006).
  PubMed PubMed Central Google Scholar
• Zen, Y. et al. Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement. Pathol. Int. 55, 180–188 (2005).
  PubMed Google Scholar
• Zen Y. et al. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod. Pathol. 20, 701–709 (2007).
  PubMed Google Scholar
• Wu, T. T., Levy, M., Correa, A. M., Rosen, C. B. & Abraham, S. C. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer 115, 4564–4575 (2009).
  PubMed Google Scholar
• Gatto, M. et al. Cholangiocarcinoma: update and future perspectives. Dig. Liver Dis. 42, 253–260 (2010).
  CAS PubMed Google Scholar
• Levy, C. et al. The value of serum CA 19–9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig. Dis. Sci. 50, 1734–1740 (2005).
  CAS PubMed Google Scholar
• Iwatsuki, S. et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J. Am. Coll. Surg. 187, 358–64 (1988).
  Google Scholar
• Rosen, C. B., Heimbach, J. K. & Gores, G. J. Liver transplantation for cholangiocarcinoma. Transpl. Int. 23, 692–697 (2010).
  PubMed Google Scholar
• Sorensen, H. T. et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 28, 921–925 (1998).
  CAS PubMed Google Scholar
• Hakamada, K. et al. Late development of bile duct cancer after sphincteroplasty: a ten- to twenty-two-year follow-up study. Surgery 121, 488–492 (1997).
  CAS PubMed Google Scholar
• Su, C. H., Shyr, Y. M., Lui, W. Y. & P'Eng, F. K. Hepatolithiasis associated with cholangiocarcinoma. Br. J. Surg. 84, 969–973 (1997).
  CAS PubMed Google Scholar
• Donato, F. et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 12, 959–964 (2001).
  CAS PubMed Google Scholar
• Lee, T. Y. et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am. J. Gastroenterol. 103, 1716–1720 (2008).
  PubMed Google Scholar
• Kobayashi, M. et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 88, 2471–2477 (2000).
  CAS PubMed Google Scholar
• Charlier, C. et al. Cholangiocarcinoma in HIV-infected patients with a history of cholangitis. J. Acquir. Immune. Defic. Syndr. 39, 253–255 (2005).
  PubMed Google Scholar
• Lowenfels, A. B. & Norman, J. Isoniazid and bile duct cancer. JAMA 240, 434–435 (1978).
  CAS PubMed Google Scholar
• Yen, S., Hsieh, C. C. & MacMahon, B. Extrahepatic bile duct cancer and smoking, beverage consumption, past medical history, and oral-contraceptive use. Cancer 59, 2112–2116 (1987).
  CAS PubMed Google Scholar
• Rubel, L. R. & Ishak, K. G. Thorotrast-associated cholangiocarcinoma: an epidemiologic and clinicopathologic study. Cancer 50, 1408–1415 (1982).
  CAS PubMed Google Scholar
• Wong, O., Whorton, M. D., Foliart, D. E. & Ragland, D. An industry-wide epidemiologic study of vinyl chloride workers, 1942–1982. Am. J. Ind. Med. 20, 317–334 (1991).
  CAS PubMed Google Scholar
• Szendroi, M., Nemeth, L. & Vajta, G. Asbestos bodies in a bile duct cancer after occupational exposure. Environ. Res. 30, 270–280 (1983).
  CAS PubMed Google Scholar
• Lipsett, P. A., Pitt, H. A., Colombani, P. M., Boitnott, J. K. & Cameron, J. L. Choledochal cyst disease. A changing pattern of presentation. Ann. Surg. 220, 644–652 (1994).
  CAS PubMed PubMed Central Google Scholar